These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34468875)

  • 1. Psoriasis and Cardiovascular Disease: Novel Mechanisms and Evolving Therapeutics.
    Weber B; Merola JF; Husni ME; Di Carli M; Berger JS; Garshick MS
    Curr Atheroscler Rep; 2021 Sep; 23(11):67. PubMed ID: 34468875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review.
    Mehta H; Narang T; Dogra S; Handa S; Hatwal J; Batta A
    Vasc Health Risk Manag; 2024; 20():215-229. PubMed ID: 38745849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Microbial Modifying Therapies to Prevent Psoriasis Exacerbation and Associated Cardiovascular Comorbidity.
    Reali E; Caliceti C; Lorenzini A; Rizzo P
    Inflammation; 2024 Feb; 47(1):13-29. PubMed ID: 37953417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities.
    Potestio L; Tommasino N; Lauletta G; Martora F; Megna M
    Dermatol Ther (Heidelb); 2024 Apr; 14(4):841-852. PubMed ID: 38592640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis Comorbidities and Their Treatment Impact.
    Taliercio M; Lebwohl M
    Dermatol Clin; 2024 Jul; 42(3):405-416. PubMed ID: 38796272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cardiometabolic risk awareness among patients with psoriasis: A quality improvement survey study.
    Kearney CA; Saha S; Mata Vivas MT; Gelfand JM; Garelik J; Lo Sicco KI; Garshick M
    JAAD Int; 2024 Sep; 16():72-74. PubMed ID: 38800703
    [No Abstract]   [Full Text] [Related]  

  • 7. Psoriasis and Cardiometabolic Comorbidities: An Evaluation of the Impact of Systemic Treatments in Randomized Clinical Trials.
    Mosca M; Hong J; Hadeler E; Hakimi M; Brownstone N; Liao W; Bhutani T
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1497-1520. PubMed ID: 34505985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network meta-analyses in psoriasis: overview and critical discussion.
    Augustin M; Valencia López M; Reich K
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):2367-2376. PubMed ID: 34506643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferences for Biologic Treatment in Patients With Psoriatic Arthritis: A Discrete Choice Experiment.
    Sumpton D; Kelly A; Craig JC; Hassett G; Kane B; Oliffe M; Tong A; Howell M
    Arthritis Care Res (Hoboken); 2022 Aug; 74(8):1234-1243. PubMed ID: 34514744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenge of Nail Psoriasis: An Update Review.
    Ji C; Wang H; Bao C; Zhang L; Ruan S; Zhang J; Gong T; Cheng B
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):377-402. PubMed ID: 34478047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study.
    Zagni E; Bianchi L; Fabbrocini G; Corrao S; Offidani A; Stingeni L; Costanzo A; Pellacani G; Peris K; Bardazzi F; Argenziano G; Ruffolo S; Dapavo P; Carrera C; Fargnoli MC; Parodi A; Romanelli M; Malagoli P; Talamonti M; Megna M; Raspanti M; Paolinelli M; Hansel K; Narcisi A; Conti A; De Simone C; Chessa MA; De Rosa A; Provenzano E; Ortoncelli M; Moltrasio C; Fidanza R; Burlando M; Tonini A; Gaiani FM; Simoni L; Zullo A; Fiocchi M; Colombo D
    BMC Health Serv Res; 2021 Sep; 21(1):924. PubMed ID: 34488749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study.
    Ogdie A; Shin DB; Love TJ; Gelfand JM
    Rheumatology (Oxford); 2022 May; 61(5):1877-1884. PubMed ID: 34508558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.
    Wu JJ; Kavanaugh A; Lebwohl MG; Gniadecki R; Merola JF
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):797-806. PubMed ID: 35238067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Extent of Subclinical Atherosclerosis and Associated Cardiovascular Risk Factors in Adult Patients With Psoriatic Arthritis: A Systematic Review.
    Jamil M; Aslam R; Patel A; Nadir B; Khan S
    Cureus; 2021 Aug; 13(8):e16853. PubMed ID: 34513433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical approaches to assess metabolic changes in psoriasis.
    Łuczaj W; Gęgotek A; Skrzydlewska E
    J Pharm Biomed Anal; 2021 Oct; 205():114359. PubMed ID: 34509137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carotid intima-media thickness in patients with psoriasis with and without metabolic syndrome.
    Ramírez-Terán AL; Vega-Memije ME; Torres-Tamayo M; Martínez-Alvarado MR
    Arch Cardiol Mex; 2022 Jul; 92(3):305-311. PubMed ID: 34499634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review and Recommendations to Combine Newer Therapies With Conventional Therapy in Psoriatic Disease.
    Arora S; Das P; Arora G
    Front Med (Lausanne); 2021; 8():696597. PubMed ID: 34490293
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of Systemic Therapies in Patients with Obesity and Psoriasis: A Single-center Retrospective Study.
    Bonifati C; Capoccia R; Graceffa D; Morrone A
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):88-93. PubMed ID: 34477074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and psoriatic arthritis are important predictors of biologic agent switch in psoriasis.
    Akdogan N; Dogan S; Bostan E; Gulseren D; Yalici-Armagan B; Elcin G; Evans SE; Karaduman A; Atakan N
    Expert Rev Clin Pharmacol; 2021 Dec; 14(12):1535-1541. PubMed ID: 34519227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should the presence of psoriatic arthritis change how we manage psoriasis?
    Chan WH; Singh R; Feldman SR
    J Dermatolog Treat; 2021 Dec; 32(8):863-865. PubMed ID: 34515604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.